The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1432
December 23, 2013
View Complete Issue         Table of Contents 2019 
A Percutaneous Device (MitraClip) for Mitral Regurgitation
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
A Percutaneous Device (MitraClip) for Mitral Regurgitation
December 23, 2013 (Issue: 1432)
The FDA has approved the use of a transcatheter mitral valve device (MitraClip – Abbott) for percutaneous treatment of significant symptomatic degenerative mitral regurgitation (grade 3-4+) in patients who are at prohibitive risk for mitral...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: A Percutaneous Device (MitraClip) for Mitral Regurgitation
Article code: 1432c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.